Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Borecký

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Acta Virologica|July 1, 1983
Interferon as therapeutic agentL Borecký, N Fuchsberger
Acta Biologica Et Medica Germanica|January 1, 1979
Production of human leukocyte interferon for clinical use under immunoelectrophoretic controlN Fuchsberger, L Borecký
Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1977
Purification of mouse interferon on specifically purified immunoadsorbentV Hajnicka, N Fuchsberger, L Borecký
Acta Virologica|April 1, 1975
Interferon-hyporesponsiveness in mice in connection with dose interval and site of administration of Newcastle disease virus. Reflexion in serum complement levelsV Rathová, D Kocisková, L Borecký
Acta Biologica Et Medica Germanica|January 1, 1979
The effect of interferon induction on complement level in ratD Kocisková, L Borecký, C Oravec
Virology|March 1, 1991
Are the acid-labile interferon alpha and interferon omega-1 identical?P Kontsek, L Borecký, M Novák
Texas Reports on Biology and Medicine|January 1, 1981
Therapeutic use of double-stranded RNAs in manL Borecký, V Lackovic, J Rovenský
Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1977
Levels of complement during interferon inductionV Rathová, D Kocisková, L Borecký
Acta Virologica|August 1, 1976
Affinity chromatography of mouse interferon: a modified purification procedure utilizing specifically purified antibodiesV Hajnická, N Fuchsberger, L Borecký
Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1977
Effect of impulsin treatment of interferon production and antiviral resistance of miceV Lackovic, L Borecký, J Kresáková
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Acta Virologica|July 1, 1983
Interferon as therapeutic agentL Borecký, N Fuchsberger
Acta Biologica Et Medica Germanica|January 1, 1979
Production of human leukocyte interferon for clinical use under immunoelectrophoretic controlN Fuchsberger, L Borecký
Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1977
Purification of mouse interferon on specifically purified immunoadsorbentV Hajnicka, N Fuchsberger, L Borecký
Acta Virologica|April 1, 1975
Interferon-hyporesponsiveness in mice in connection with dose interval and site of administration of Newcastle disease virus. Reflexion in serum complement levelsV Rathová, D Kocisková, L Borecký
Acta Biologica Et Medica Germanica|January 1, 1979
The effect of interferon induction on complement level in ratD Kocisková, L Borecký, C Oravec
Virology|March 1, 1991
Are the acid-labile interferon alpha and interferon omega-1 identical?P Kontsek, L Borecký, M Novák
Texas Reports on Biology and Medicine|January 1, 1981
Therapeutic use of double-stranded RNAs in manL Borecký, V Lackovic, J Rovenský
Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1977
Levels of complement during interferon inductionV Rathová, D Kocisková, L Borecký
Acta Virologica|August 1, 1976
Affinity chromatography of mouse interferon: a modified purification procedure utilizing specifically purified antibodiesV Hajnická, N Fuchsberger, L Borecký
Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1977
Effect of impulsin treatment of interferon production and antiviral resistance of miceV Lackovic, L Borecký, J Kresáková
Pageof 6